Rosenblatt Maintains Buy on Adtran, Lowers Price Target to $11
Portfolio Pulse from richadhand@benzinga.com
Rosenblatt analyst Mike Genovese has maintained a 'Buy' rating on Adtran (NASDAQ:ADTN) but lowered the price target from $12 to $11.

August 09, 2023 | 11:34 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Adtran's price target has been lowered from $12 to $11 by Rosenblatt, though the 'Buy' rating is maintained.
The lowering of the price target by Rosenblatt could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the stock, which could counterbalance the negative sentiment to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100